major challenge in front of cellular therapy advancement. Many factors, ranging from
geneticDzhaubermezov, M.,
Ekomasova, N.,
Mustafin, R.,
Gabidullina, L.,
Galimova, Y.,
Nurgalieva, A.,
Valova, Y.,
Prokofyeva, D.,
Khusnutdinova, E. (2022) Genetic Polymorphisms of Cytochromes P450 in Finno-Permic Populations of Russia
MicroRNAs as potential diagnostic
markers of glial brain tumors
Mingazheva, E.T.,
Prokofyeva, D.S.,
Valova, Ya.V.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Valiev, R.R.,
Ekomasova, N.V.,
Faishanova, R.R.,
Romanova, A.R.,
Khusnutdinova, E.K. (2022) 2, CHEK2 and NBN genes,
potentially pathogenic
genetic variants in new breast and ovarian cancer
Gilyazova, I.R.,
Ivanova, E.A.,
Bermisheva, M.A.,
Loginova, M.V.,
Asadullina, D.D.,
Ishemgulov, R.R.,
Mustafin, A.T.,
Pavlov, V.N.,
Khusnutdinova, E.K. (2022) be used to create a panel of molecular
markers for disease prognosis and assessment of tumor
MicroRNAs as prognostic
markers and therapeutic targets in gliomas